Scandinavian journal of clinical and laboratory investigation
-
Scand. J. Clin. Lab. Invest. · Mar 2014
Neutrophil gelatinase-associated lipocalin (NGAL) for the early detection of contrast-induced nephropathy after percutaneous coronary intervention.
Contrast-induced acute kidney injury (CI-AKI) occurs in up to 13% of patients undergoing percutaneous coronary intervention (PCI). Neutrophil gelatinase-associated lipocalin (NGAL) is an early biomarker for renal impairment. We investigated whether increased urinary NGAL concentrations were predictive of CI-AKI within 2 days after PCI or of a higher re-hospitalization rate within 9 months. ⋯ Urinary NGAL is a biomarker for predicting CI-AKI when measured 1 day after PCI.